CMS 347v8: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
Measure: Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period:
|
||
Measure Type | High Priority Measure | Scoring |
Process | No | A higher percentage indicates better quality |
Denominator |
Denominator 1: All patients who were previously diagnosed with or currently have a diagnosis of clinical ASCVD, including an ASCVD procedure Denominator 2: Patients aged 20 to 75 years at the beginning of the measurement period who have ever had a laboratory result of LDL-C ≥ 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia Denominator 3: Patients aged 40-75 years at the beginning of the measurement period with Type 1 or Type 2 diabetes Denominator 4: Patients aged 40-75 at the beginning of the measurement period with a 10-year ASCVD risk score (i.e., 2013 ACC/AHA ASCVD Risk Estimator or the ACC Risk Estimator Plus) of ≥ 20 percent during the measurement period. |
Numerator | Patients who are actively using or who receive an order (prescription) for statin therapy at any time during the measurement period |
Denominator Exceptions |
|
Denominator Exclusions |
|
Return to 2025 eCQMs
Didn't find the answer you were looking for?
Contact Sevocity Support 24/7 at 877‑777‑2298 or support@sevocity.com